Safety and Efficacy of AL-53817 Nasal Spray Solution

Summary

The purpose of this study was to determine the maximum tolerated dose of AL-53817 (Stage A) and evaluate the safety and efficacy of AL-53817 for the treatment of allergic rhinitis (Stage B).

Timeline

Start

2011-10

Primary completion

2012-03

Completion

2012-03

Drugs

Indications